Tuesday, October 6, 2015

Otonomy Receives FDA Clearance of Investigational New Drug Application for Tinnitus Product Candidate, OTO-311

SAN DIEGO, Oct. 5, 2015 – (Healthcare Sales & Marketing Network) – Otonomy, Inc. (OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today a… Biopharmaceuticals, FDAOtonomy, OTO-311, tinnitus (Source: HSMN NewsFeed)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

from Tinnitus Miracle Book http://ift.tt/1OUYV7B via tinnitus definition
from Tumblr http://ift.tt/1Gu12aE

No comments:

Post a Comment